Publications
60
Citations
191
Est. group size
~2
Recurring co-author estimate
Active years
31
Publishing since 1996
Yusuf Açıkgöz is a medical oncologist whose work centers on the treatment and prognosis of solid tumors, including gastric, lung, renal cell, and esophageal cancers. Much of the research involves identifying prognostic and predictive biomarkers (such as blood-based inflammation markers, muscle mass, and molecular markers) to help guide treatment decisions and evaluating outcomes of chemotherapy, immunotherapy, and radiotherapy regimens in cancer patients.
Publication output rose sharply around 2019-2020, then gradually declined through the early 2020s, with a recent uptick reflected in 2026 publication dates.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Immunotherapy-induced vitiligo and demyelinating plaques: a case report suggesting a neurocutaneous mechanism
Neurological Sciences · 2026
- KIF11 as a druggable target in NSCLC: An integrated computational analysis.
Journal of Clinical Oncology · 2026
- Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab
Radiology and Oncology · 2025
- The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer
Oncology · 2024
- Impact of <sup>68</sup>Ga-PSMA PET/CT on Survival and Management in Prostate Cancer
Current Medical Imaging Formerly Current Medical Imaging Reviews · 2024
- Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data
Cancer Management and Research · 2023
- Simple and easily accessible prognostic markers in ewing sarcoma; neutrophil-lymphocyte ratio, neutrophil-platelet score and systemic-inflammation index
Journal of Cancer Research and Therapeutics · 2023
- The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer
American Journal of Clinical Oncology · 2023
- The effectiveness of adjuvant treatment approaches for resectable esophageal cancer: A single-center experience
Journal of Cancer Research and Therapeutics · 2023
- Nutritional Health in Premenopausal Women: A Cross-Sectional Study from Turkey
International Journal of Preventive Medicine · 2022
- First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma
Bosnian Journal of Basic Medical Sciences · 2022
- Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell Carcinoma
Journal of Oncological Sciences · 2022
- Clinicopathologİcal Features and Survival Outcomes of 70 Tongue Squamous Cell Carcinoma Patients
Acta Oncologica Turcica · 2022
- 120P Efficacy of postoperative radiotherapy (PORT) in stage IIIA-N2 non-small cell lung cancer: Meta-analysis of randomized controlled studies
Annals of Oncology · 2022
- The prognostic value of Sprouty2 protein in nonsmall cell lung cancer.
Journal of Clinical Oncology · 2022
- Annals of Oncology×4
- Journal of Clinical Oncology×4
- Journal of Cancer Research and Therapeutics×3
- Acta Oncologica Turcica×3
- Research Square×3
- Mingjia Li
Medicine · The Ohio State University
- Wei Chen
Medicine · The Ohio State University
- Ha Tran
Medicine · The Ohio State University
- Bert H. O’Neil
Medicine · Indiana University
- Eric D. Miller
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile